PresentationWelcome to our fireside chat with Nurix. I am Robert Burns, Managing Director and Senior Biotech analyst at H.C. Wainwright. And I'm joined by Arthur Sands, the CEO of Nurix. Arthur, thank you for joining us today.Arthur SandsCEO, President & Director I do. I'll start out with a few slides just to frame things. We have our disclaimers, of course. So as we will be talking extensively about targeted protein degradation, I want to take a step back with this first slide and look at how we see it fit ...